Romain Lara
Associate Director AstraZeneca
Seminars
Wednesday 2nd December 2026
Evidence – Using CRISPR Screening to Decode Tumour Microenvironment Biology & Identify Next Generation Immunotherapy Targets
4:00 pm
- Applying CRISPR-based approaches to uncover mechanisms of immune suppression within the tumour microenvironment
- Leveraging advanced tumour models to identify and validate novel immuno-oncology targets
- Using translationally relevant systems to prioritise targets with the greatest potential to drive durable anti-tumour responses
